Menu Search
Equities

Episurf Medical AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert
16E:STU

Episurf Medical AB

Actions
  • Price (EUR)0.0007
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-94.29%
  • Beta0.7487
Data delayed at least 15 minutes, as of Feb 17 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Episurf Medical AB grew revenues 22.90% from 13.10m to 16.10m while net income improved from a loss of 76.10m to a smaller loss of 58.30m.
Gross margin--
Net profit margin-357.14%
Operating margin-359.63%
Return on assets-72.97%
Return on equity-88.50%
Return on investment-86.27%
More ▼

Cash flow in SEKView more

In 2025, cash reserves at Episurf Medical AB fell by 43.40m. Cash Flow from Financing totalled 18.60m or 115.53% of revenues. In addition the company used 55.40m for operations while cash used for investing totalled 6.70m.
Cash flow per share-0.0423
Price/Cash flow per share--
Book value per share0.0286
Tangible book value per share0.0063
More ▼

Balance sheet in SEKView more

Episurf Medical AB has a Debt to Total Capital ratio of 9.35%.
Current ratio1.70
Quick ratio1.41
Total debt/total equity0.1032
Total debt/total capital0.0935
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.